← Leaderboards
George Y Liu
Cedars-Sinai Medical Center
$11,032,137
Attributed
$15,852,336
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,852,336 · 12
By mechanism
R01$13,819,827 · 6
R21$1,780,665 · 4
R41$250,000 · 1
M01$1,844 · 1
Top collaborators
- David M. Underhill7 shared
- Gislaine A Martins5 shared
- Ramachandran Murali5 shared
- Clarence Buddy Creech3 shared
- Steven Qian1 shared
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionImmuneStaphylococcus AureusBaseAntibiotic ResistanceVaccinesMouse ModelIn VitroImmune ResponsePathogenResponseImmunitySkinVaccinationInflammationEnzymesInflammatoryVaccine EvaluationAffectIn VivoStaphylococcus Aureus InfectionExperimental StudyStaphylococcal InfectionsHumanized Mouse
Grant awards (35)
Interrogating human anti-staphylococcal antibody responses for S. aureus vaccine insights$808,814
R01 · FY2025 · AI · contact PI
Mechanisms of vaccine interference by S. aureus-induced imprints$714,925
R01 · FY2025 · AI · contact PI
Interrogating human anti-staphylococcal antibody responses for S. aureus vaccine insights$813,730
R01 · FY2024 · AI · contact PI
Mechanisms of vaccine interference by S. aureus-induced imprints$750,580
R01 · FY2024 · AI · contact PI
Interrogating human anti-staphylococcal antibody responses for S. aureus vaccine insights$818,825
R01 · FY2023 · AI · contact PI
Staphylococcus aureus interference with IsdB vaccination$572,061
R01 · FY2023 · AI · contact PI
Pathogenic and protective roles of strain-specific P. acnes hyaluronidases in acne$479,531
R01 · FY2023 · AI
Staphylococcus aureus interference with IsdB vaccination$572,061
R01 · FY2022 · AI · contact PI
Pathogenic and protective roles of strain-specific P. acnes hyaluronidases in acne$491,254
R01 · FY2022 · AI
Pathogenic and protective roles of strain-specific P. acnes hyaluronidases in acne$601,122
R01 · FY2021 · AI
Generating protective immunity to Staphylococcus aureus$574,032
R01 · FY2021 · AI
Staphylococcus aureus interference with IsdB vaccination$543,136
R01 · FY2021 · AI · contact PI
Eliminating Acne Through Photo-Inactivation Catalase$250,000
R41 · FY2021 · AR
Pathogenic and protective roles of strain-specific P. acnes hyaluronidases in acne$675,242
R01 · FY2020 · AI
Generating protective immunity to Staphylococcus aureus$581,032
R01 · FY2020 · AI
Staphylococcus aureus interference with IsdB vaccination$541,789
R01 · FY2020 · AI · contact PI
Staphylococcus aureus interference with IsdB vaccination$555,894
R01 · FY2019 · AI · contact PI
Generating protective immunity to Staphylococcus aureus$550,625
R01 · FY2019 · AI
Pathogenic and protective roles of strain-specific P. acnes hyaluronidases in acne$480,729
R01 · FY2019 · AI
Impact of P. acnes hyaluronidases on acne pathogenesis$229,312
R21 · FY2019 · AI · contact PI
Generating protective immunity to Staphylococcus aureus$560,600
R01 · FY2018 · AI
Impact of P. acnes hyaluronidases on acne pathogenesis$174,863
R21 · FY2018 · AI · contact PI
Impact of P. acnes hyaluronidases on acne pathogenesis$23,365
R21 · FY2018 · AI · contact PI
Generating protective immunity to Staphylococcus aureus$570,400
R01 · FY2017 · AI
Nicotinamide-An Immune-Boosting Agent to Combat Antibiotic-Resistant Pathogens$255,000
R21 · FY2015 · AI · contact PI
Bacterial Manipulation of Host Hyaluronan Degradation for Immune Evasion$250,500
R21 · FY2014 · AI · contact PI
Nicotinamide-An Immune-Boosting Agent to Combat Antibiotic-Resistant Pathogens$212,500
R21 · FY2014 · AI · contact PI
Impact of Antibiotics and PBP2a on the Immunopathology of MRSA pneumonia$232,650
R21 · FY2013 · AI · contact PI
Bacterial Manipulation of Host Hyaluronan Degradation for Immune Evasion$196,225
R21 · FY2013 · AI · contact PI
Impact of Antibiotics and PBP2a on the Immunopathology of MRSA pneumonia$206,250
R21 · FY2012 · AI · contact PI
Antioxidant-based mechanisms used by staphyloccocus aureus to evade host defenses$386,049
R01 · FY2010 · AI · contact PI
STUDY TO DETERMINE HOW COMMUNITY ASSOCIATED MRSA SURVIVES ON HUMAN SKIN$1,844
M01 · FY2010 · RR · contact PI
Antioxidant-based mechanisms used by staphyloccocus aureus to evade host defenses$389,948
R01 · FY2009 · AI · contact PI
Antioxidant-based mechanisms used by staphyloccocus aureus to evade host defenses$389,948
R01 · FY2008 · AI · contact PI
Antioxidant-based mechanisms used by staphyloccocus aureus to evade host defenses$397,500
R01 · FY2007 · AI · contact PI